Evaluation of Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome

NCT04718025 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

4500

Enrollment

OTHER

Sponsor class

Conditions

STEMI
NSTEMI
Unstable Angina

Interventions

DRUG: Ticagrelor 90mg
DRUG: Ticagrelor 60mg
DRUG: Aspirin

Sponsor

Collegium Medicum w Bydgoszczy

Collaborators

[object Object]